These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 21352823

  • 1. Local modulation of striatal glutamate efflux by serotonin 1A receptor stimulation in dyskinetic, hemiparkinsonian rats.
    Dupre KB, Ostock CY, Eskow Jaunarajs KL, Button T, Savage LM, Wolf W, Bishop C.
    Exp Neurol; 2011 Jun; 229(2):288-99. PubMed ID: 21352823
    [Abstract] [Full Text] [Related]

  • 2. Striatal 5-HT1A receptor stimulation reduces D1 receptor-induced dyskinesia and improves movement in the hemiparkinsonian rat.
    Dupre KB, Eskow KL, Barnum CJ, Bishop C.
    Neuropharmacology; 2008 Dec; 55(8):1321-8. PubMed ID: 18824001
    [Abstract] [Full Text] [Related]

  • 3. Effects of 5-HT1A receptor stimulation on striatal and cortical M1 pERK induction by L-DOPA and a D1 receptor agonist in a rat model of Parkinson's disease.
    Lindenbach D, Dupre KB, Eskow Jaunarajs KL, Ostock CY, Goldenberg AA, Bishop C.
    Brain Res; 2013 Nov 06; 1537():327-39. PubMed ID: 24060645
    [Abstract] [Full Text] [Related]

  • 4. Contribution of the striatum to the effects of 5-HT1A receptor stimulation in L-DOPA-treated hemiparkinsonian rats.
    Bishop C, Krolewski DM, Eskow KL, Barnum CJ, Dupre KB, Deak T, Walker PD.
    J Neurosci Res; 2009 May 15; 87(7):1645-58. PubMed ID: 19115412
    [Abstract] [Full Text] [Related]

  • 5. Effects of 5-HT1A receptor stimulation on D1 receptor agonist-induced striatonigral activity and dyskinesia in hemiparkinsonian rats.
    Dupre KB, Ostock CY, George JA, Eskow Jaunarajs KL, Hueston CM, Bishop C.
    ACS Chem Neurosci; 2013 May 15; 4(5):747-60. PubMed ID: 23496922
    [Abstract] [Full Text] [Related]

  • 6. Striatal glutamate release in L-DOPA-induced dyskinetic animals.
    Nevalainen N, Lundblad M, Gerhardt GA, Strömberg I.
    PLoS One; 2013 May 15; 8(2):e55706. PubMed ID: 23390548
    [Abstract] [Full Text] [Related]

  • 7. Effects of coincident 5-HT1A receptor stimulation and NMDA receptor antagonism on L-DOPA-induced dyskinesia and rotational behaviors in the hemi-parkinsonian rat.
    Dupre KB, Eskow KL, Steiniger A, Klioueva A, Negron GE, Lormand L, Park JY, Bishop C.
    Psychopharmacology (Berl); 2008 Jul 15; 199(1):99-108. PubMed ID: 18545986
    [Abstract] [Full Text] [Related]

  • 8. Effects of prolonged selective serotonin reuptake inhibition on the development and expression of L-DOPA-induced dyskinesia in hemi-parkinsonian rats.
    Conti MM, Ostock CY, Lindenbach D, Goldenberg AA, Kampton E, Dell'isola R, Katzman AC, Bishop C.
    Neuropharmacology; 2014 Feb 15; 77():1-8. PubMed ID: 24067924
    [Abstract] [Full Text] [Related]

  • 9. The differential effects of 5-HT(1A) receptor stimulation on dopamine receptor-mediated abnormal involuntary movements and rotations in the primed hemiparkinsonian rat.
    Dupre KB, Eskow KL, Negron G, Bishop C.
    Brain Res; 2007 Jul 16; 1158():135-43. PubMed ID: 17553470
    [Abstract] [Full Text] [Related]

  • 10. The novel 5-HT1A receptor agonist, NLX-112 reduces l-DOPA-induced abnormal involuntary movements in rat: A chronic administration study with microdialysis measurements.
    McCreary AC, Varney MA, Newman-Tancredi A.
    Neuropharmacology; 2016 Jun 16; 105():651-660. PubMed ID: 26777281
    [Abstract] [Full Text] [Related]

  • 11. Activity of serotonin 5-HT(1A) receptor 'biased agonists' in rat models of Parkinson's disease and L-DOPA-induced dyskinesia.
    Iderberg H, McCreary AC, Varney MA, Cenci MA, Newman-Tancredi A.
    Neuropharmacology; 2015 Jun 16; 93():52-67. PubMed ID: 25645393
    [Abstract] [Full Text] [Related]

  • 12. Characterizing the differential roles of striatal 5-HT1A auto- and hetero-receptors in the reduction of l-DOPA-induced dyskinesia.
    Meadows SM, Chambers NE, Conti MM, Bossert SC, Tasber C, Sheena E, Varney M, Newman-Tancredi A, Bishop C.
    Exp Neurol; 2017 Jun 16; 292():168-178. PubMed ID: 28342749
    [Abstract] [Full Text] [Related]

  • 13. Effects of L-dopa priming on cortical high beta and high gamma oscillatory activity in a rodent model of Parkinson's disease.
    Dupre KB, Cruz AV, McCoy AJ, Delaville C, Gerber CM, Eyring KW, Walters JR.
    Neurobiol Dis; 2016 Feb 16; 86():1-15. PubMed ID: 26586558
    [Abstract] [Full Text] [Related]

  • 14. Modulating mGluR5 and 5-HT1A/1B receptors to treat l-DOPA-induced dyskinesia: effects of combined treatment and possible mechanisms of action.
    Iderberg H, Rylander D, Bimpisidis Z, Cenci MA.
    Exp Neurol; 2013 Dec 16; 250():116-24. PubMed ID: 24029003
    [Abstract] [Full Text] [Related]

  • 15. Eltoprazine prevents levodopa-induced dyskinesias by reducing striatal glutamate and direct pathway activity.
    Paolone G, Brugnoli A, Arcuri L, Mercatelli D, Morari M.
    Mov Disord; 2015 Nov 16; 30(13):1728-38. PubMed ID: 26207892
    [Abstract] [Full Text] [Related]

  • 16. Role of dopamine D3 and serotonin 5-HT 1A receptors in L: -DOPA-induced dyskinesias and effects of sarizotan in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
    Gerlach M, Bartoszyk GD, Riederer P, Dean O, van den Buuse M.
    J Neural Transm (Vienna); 2011 Dec 16; 118(12):1733-42. PubMed ID: 21253782
    [Abstract] [Full Text] [Related]

  • 17. Effects of the Serotonin 5-HT1A Receptor Biased Agonists, F13714 and F15599, on Striatal Neurotransmitter Levels Following L-DOPA Administration in Hemi-Parkinsonian Rats.
    Newman-Tancredi A, Varney MA, McCreary AC.
    Neurochem Res; 2018 May 16; 43(5):1035-1046. PubMed ID: 29572645
    [Abstract] [Full Text] [Related]

  • 18. Role of the primary motor cortex in L-Dopa-induced dyskinesia and its modulation by 5-HT1A receptor stimulation.
    Ostock CY, Dupre KB, Jaunarajs KL, Walters H, George J, Krolewski D, Walker PD, Bishop C.
    Neuropharmacology; 2011 Sep 16; 61(4):753-60. PubMed ID: 21635907
    [Abstract] [Full Text] [Related]

  • 19. The partial 5-HT(1A) agonist buspirone reduces the expression and development of l-DOPA-induced dyskinesia in rats and improves l-DOPA efficacy.
    Eskow KL, Gupta V, Alam S, Park JY, Bishop C.
    Pharmacol Biochem Behav; 2007 Sep 16; 87(3):306-14. PubMed ID: 17553556
    [Abstract] [Full Text] [Related]

  • 20. Combined 5-HT1A and 5-HT1B receptor agonists for the treatment of L-DOPA-induced dyskinesia.
    Muñoz A, Li Q, Gardoni F, Marcello E, Qin C, Carlsson T, Kirik D, Di Luca M, Björklund A, Bezard E, Carta M.
    Brain; 2008 Dec 16; 131(Pt 12):3380-94. PubMed ID: 18952677
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.